Bayer will apply for approval to make its blockbuster blood thinner Xarelto available for treating children, the German company said on Monday, after a study showed strong efficacy and safety in children with thromboembolism.
from Reuters: Health News https://ift.tt/2L7PQxq
via
IFTTT
0 comments:
Post a Comment